We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Copy number variation and cytidine analogue cytotoxicity: a genome-wide association approach.
- Authors
Kalari, Krishna R; Hebbring, Scott J; Chai, High Seng; Li, Liang; Kocher, Jean-Pierre A; Wang, Liewei; Weinshilboum, Richard M
- Abstract
The human genome displays extensive copy-number variation (CNV). Recent discoveries have shown that large segments of DNA, ranging in size from hundreds to thousands of nucleotides, are either deleted or duplicated. This CNV may encompass genes, leading to a change in phenotype, including drug response phenotypes. Gemcitabine and 1-beta-D-arabinofuranosylcytosine (AraC) are cytidine analogues used to treat a variety of cancers. Previous studies have shown that genetic variation may influence response to these drugs. In the present study, we set out to test the hypothesis that variation in copy number might contribute to variation in cytidine analogue response phenotypes.
- Publication
BMC genomics, 2010, Vol 11, p357
- ISSN
1471-2164
- Publication type
Journal Article
- DOI
10.1186/1471-2164-11-357